Regenerative Science
The science of regenerative medicine is an innovative and expanding field, developing the potential for tissue engineering to offer enhance natural recovery by triggering responses through the body’s own cells enabling the natural regeneration of the patient’s own tissues.
Our Technology
We use our innovative platform technologies to address clinical needs in the regenerative medicine market. Our technologies dCELL® and BioRinse™ are complementary bone and soft tissue platforms.
About Tissue Regenix Group
Tissue Regenix Group are a leading manufacturer of allografts and xenografts processing products that utilize our proprietary BioRinse™ and dCELL® technology platforms designed to enhance patient outcomes.
We operate from two locations in San Antonio, Texas (formerly CellRight Technologies) and Leeds, UK.
Our San Antonio location processes, stores, and distributes Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) to hospitals, medical professionals, and approved distribution partners in compliance with the requirements of the FDA and state regulations, AATB Standards, and other international requirements. We are AATB-accredited and registered with the FDA.
Our Leeds location houses our corporate offices and is responsible for porcine tissue medical device manufacturing and distribution, including the OrthoPure® XT Ligament Reconstruction Implant. This facility is certified to ISO 13485:2016. With strong connections to the University of Leeds, this facility also acts as the research and development hub for potential future portfolio developments.
Our Products
We focus on the development of regenerative products utilising our two platform technologies to transform the treatment of patients and provide differentiated clinical outcomes in key clinical areas.